Lebanon vs Peru: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Lebanon
0.1%
in 2024
Peru
0.1%
in 2024
Lebanon rank
112th
Peru rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Lebanon
- Peru
How they compare
Lebanon currently reports 0.1% against 0.1% in Peru, a difference of 0.0%.
Across all 10 years both countries report, Peru has been ahead every year.
Lebanon ranks 112th and Peru ranks 112th of 215 countries.
Peru has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Peru |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Lebanon or Peru?
- Lebanon, at 0.1% against 0.1% in Peru as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Lebanon and Peru?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Peru?
- 10 years are reported by both, from 2015 to 2024.
- How do Lebanon and Peru rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lebanon ranks 112th and Peru ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.